{"actionType":"INHIBITOR","mechanismOfAction":"Programmed cell death protein 1 inhibitor","chemblIds":["CHEMBL4594578"],"targetName":"Programmed cell death protein 1","targetType":"single protein","targets":["ENSG00000188389"],"references":[{"source":"Other","ids":["https://cancerres.aacrjournals.org/content/76/14_Supplement/3217","https://cancerres.aacrjournals.org/content/76/14_Supplement/3217"],"urls":["https://cancerres.aacrjournals.org/content/76/14_Supplement/3217","https://cancerres.aacrjournals.org/content/76/14_Supplement/3217"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA topoisomerase II inhibitor","chemblIds":["CHEMBL3545337","CHEMBL338604"],"targetName":"DNA topoisomerase II","targetType":"protein family","targets":["ENSG00000131747","ENSG00000077097"],"references":[{"source":"PubMed","ids":["23823138","25896848","8622625","23823138","25896848"],"urls":["http://europepmc.org/abstract/MED/23823138","http://europepmc.org/abstract/MED/25896848","http://europepmc.org/abstract/MED/8622625","http://europepmc.org/abstract/MED/23823138","http://europepmc.org/abstract/MED/25896848"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"HLA-DR antigens-associated invariant chain antagonist","chemblIds":["CHEMBL1743040"],"targetName":"HLA-DR antigens-associated invariant chain","targetType":"single protein","targets":["ENSG00000019582"],"references":[{"source":"PubMed","ids":["22404985"],"urls":["http://europepmc.org/abstract/MED/22404985"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL1084172","CHEMBL1198857"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"FDA","ids":["label/2013/204275s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204275s000lbl.pdf"]}]}
{"actionType":"ACTIVATOR","mechanismOfAction":"Soluble guanylate cyclase activator","chemblIds":["CHEMBL1200689"],"targetName":"Soluble guanylate cyclase","targetType":"protein complex group","targets":["ENSG00000061918","ENSG00000123201","ENSG00000152402","ENSG00000164116"],"references":[{"source":"Wikipedia","ids":["Soluble_guanylyl_cyclase"],"urls":["http://en.wikipedia.org/wiki/Soluble_guanylyl_cyclase"]},{"source":"DailyMed","ids":["setid=762b51be-1893-4cd1-9511-e645fc420d3a#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=762b51be-1893-4cd1-9511-e645fc420d3a#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"MAP kinase-activated protein kinase 5 inhibitor","chemblIds":["CHEMBL3545338"],"targetName":"MAP kinase-activated protein kinase 5","targetType":"single protein","targets":["ENSG00000089022"],"references":[{"source":"PubMed","ids":["22950522"],"urls":["http://europepmc.org/abstract/MED/22950522"]},{"source":"Other","ids":["http://www.rsc.org/images/MartinAndrews_tcm18-195242.pdf"],"urls":["http://www.rsc.org/images/MartinAndrews_tcm18-195242.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial DNA gyrase inhibitor","chemblIds":["CHEMBL240163"],"targetName":"Bacterial DNA gyrase","targetType":"protein complex","targets":[],"references":[{"source":"Other","ids":["https://clinicaltrials.gov/ProvidedDocs/42/NCT03696342/Prot_000.pdf","https://clinicaltrials.gov/ProvidedDocs/42/NCT03696342/Prot_000.pdf"],"urls":["https://clinicaltrials.gov/ProvidedDocs/42/NCT03696342/Prot_000.pdf","https://clinicaltrials.gov/ProvidedDocs/42/NCT03696342/Prot_000.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Progesterone receptor antagonist","chemblIds":["CHEMBL1276308"],"targetName":"Progesterone receptor","targetType":"single protein","targets":["ENSG00000082175"],"references":[{"source":"DailyMed","ids":["setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9","setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9"]},{"source":"PubMed","ids":["22466348"],"urls":["http://europepmc.org/abstract/MED/22466348"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","chemblIds":["CHEMBL3544910"],"targetName":"Ribonucleoside-diphosphate reductase RR1","targetType":"protein complex group","targets":["ENSG00000167325","ENSG00000048392","ENSG00000171848"],"references":[{"source":"PubMed","ids":["16481328","18979503","23513243","16481328","18979503","19121624","23513243"],"urls":["http://europepmc.org/abstract/MED/16481328","http://europepmc.org/abstract/MED/18979503","http://europepmc.org/abstract/MED/23513243","http://europepmc.org/abstract/MED/16481328","http://europepmc.org/abstract/MED/18979503","http://europepmc.org/abstract/MED/19121624","http://europepmc.org/abstract/MED/23513243"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA topoisomerase I inhibitor","chemblIds":["CHEMBL124162"],"targetName":"DNA topoisomerase I","targetType":"single protein","targets":["ENSG00000198900"],"references":[{"source":"PubMed","ids":["19458069"],"urls":["http://europepmc.org/abstract/MED/19458069"]},{"source":"ClinicalTrials","ids":["NCT02575638"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT02575638"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Pyrimidinergic receptor P2Y6 agonist","chemblIds":["CHEMBL1767408","CHEMBL221326"],"targetName":"Pyrimidinergic receptor P2Y6","targetType":"single protein","targets":["ENSG00000171631"],"references":[{"source":"Other","ids":["https://www.pmda.go.jp/files/000153954.pdf","https://www.pmda.go.jp/files/000153954.pdf","https://www.pmda.go.jp/files/000153954.pdf","https://www.pmda.go.jp/files/000153954.pdf"],"urls":["https://www.pmda.go.jp/files/000153954.pdf","https://www.pmda.go.jp/files/000153954.pdf","https://www.pmda.go.jp/files/000153954.pdf","https://www.pmda.go.jp/files/000153954.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"MAP kinase p38 alpha inhibitor","chemblIds":["CHEMBL585902"],"targetName":"MAP kinase p38 alpha","targetType":"single protein","targets":["ENSG00000112062"],"references":[{"source":"PubMed","ids":["21513885"],"urls":["http://europepmc.org/abstract/MED/21513885"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","chemblIds":["CHEMBL1200379","CHEMBL647"],"targetName":"Adrenergic receptor alpha-2","targetType":"protein family","targets":["ENSG00000150594","ENSG00000184160","ENSG00000274286"],"references":[{"source":"DailyMed","ids":["setid=dc7d3a9f-c0b9-411c-9c62-0a14f1718b00"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc7d3a9f-c0b9-411c-9c62-0a14f1718b00"]}]}
{"actionType":"INVERSE AGONIST","mechanismOfAction":"Histamine H1 receptor inverse agonist","chemblIds":["CHEMBL305660"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"PubMed","ids":["19032340","21437146","2905150","8828021","8828024"],"urls":["http://europepmc.org/abstract/MED/19032340","http://europepmc.org/abstract/MED/21437146","http://europepmc.org/abstract/MED/2905150","http://europepmc.org/abstract/MED/8828021","http://europepmc.org/abstract/MED/8828024"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase JAK2 inhibitor","chemblIds":["CHEMBL3545215"],"targetName":"Tyrosine-protein kinase JAK2","targetType":"single protein","targets":["ENSG00000096968"],"references":[{"source":"PubMed","ids":["22015772","24766055"],"urls":["http://europepmc.org/abstract/MED/22015772","http://europepmc.org/abstract/MED/24766055"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Reticulon-4 inhibitor","chemblIds":["CHEMBL1742987"],"targetName":"Reticulon-4","targetType":"single protein","targets":["ENSG00000115310"],"references":[{"source":"Other","ids":["http://www.creativebiolabs.net/Anti-Human-RTN-4-Therapeutic-Antibody-Atinumab-13534.htm"],"urls":["http://www.creativebiolabs.net/Anti-Human-RTN-4-Therapeutic-Antibody-Atinumab-13534.htm"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"LDL-associated phospholipase A2 inhibitor","chemblIds":["CHEMBL204021"],"targetName":"LDL-associated phospholipase A2","targetType":"single protein","targets":["ENSG00000146070"],"references":[{"source":"PubMed","ids":["24678955"],"urls":["http://europepmc.org/abstract/MED/24678955"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"DNA cross-linking agent","chemblIds":["CHEMBL4297871"],"references":[{"source":"Other","ids":["https://ashpublications.org/blood/article/136/Supplement%201/21/470217/Preliminary-Results-of-a-Phase-2-Study-of","https://ashpublications.org/blood/article/136/Supplement%201/21/470217/Preliminary-Results-of-a-Phase-2-Study-of"],"urls":["https://ashpublications.org/blood/article/136/Supplement%201/21/470217/Preliminary-Results-of-a-Phase-2-Study-of","https://ashpublications.org/blood/article/136/Supplement%201/21/470217/Preliminary-Results-of-a-Phase-2-Study-of"]},{"source":"PubMed","ids":["27535974","32912922","27535974","32912922"],"urls":["http://europepmc.org/abstract/MED/27535974","http://europepmc.org/abstract/MED/32912922","http://europepmc.org/abstract/MED/27535974","http://europepmc.org/abstract/MED/32912922"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL296419"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"PubMed","ids":["6114717"],"urls":["http://europepmc.org/abstract/MED/6114717"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL126"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"PubMed","ids":["15992144"],"urls":["http://europepmc.org/abstract/MED/15992144"]},{"source":"DailyMed","ids":["setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd"]}]}
{"actionType":"RELEASING AGENT","mechanismOfAction":"Norepinephrine transporter releasing agent","chemblIds":["CHEMBL1201483","CHEMBL1590"],"targetName":"Norepinephrine transporter","targetType":"single protein","targets":["ENSG00000103546"],"references":[{"source":"ISBN","ids":["9780702034718 PP. 191"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"Wikipedia","ids":["Adrenergic_agonist","Adrenergic_receptor","Decongestant","Pseudoephedrine"],"urls":["http://en.wikipedia.org/wiki/Adrenergic_agonist","http://en.wikipedia.org/wiki/Adrenergic_receptor","http://en.wikipedia.org/wiki/Decongestant","http://en.wikipedia.org/wiki/Pseudoephedrine"]},{"source":"PubMed","ids":["12373557","19948186"],"urls":["http://europepmc.org/abstract/MED/12373557","http://europepmc.org/abstract/MED/19948186"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 2c (5-HT2c) receptor antagonist","chemblIds":["CHEMBL2104986"],"targetName":"Serotonin 2c (5-HT2c) receptor","targetType":"single protein","targets":["ENSG00000147246"],"references":[{"source":"Other","ids":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"],"urls":["http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788","http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false","https://www.google.com/patents/US20100144788"]},{"source":"Wikipedia","ids":["Tedatioxetine","Tedatioxetine","Tedatioxetine","Tedatioxetine","Tedatioxetine","Tedatioxetine","Tedatioxetine"],"urls":["http://en.wikipedia.org/wiki/Tedatioxetine","http://en.wikipedia.org/wiki/Tedatioxetine","http://en.wikipedia.org/wiki/Tedatioxetine","http://en.wikipedia.org/wiki/Tedatioxetine","http://en.wikipedia.org/wiki/Tedatioxetine","http://en.wikipedia.org/wiki/Tedatioxetine","http://en.wikipedia.org/wiki/Tedatioxetine"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucagon receptor agonist","chemblIds":["CHEMBL3545269"],"targetName":"Glucagon receptor","targetType":"single protein","targets":["ENSG00000215644"],"references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800041034"],"urls":["http://adisinsight.springer.com/drugs/800041034"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Tumor necrosis factor receptor superfamily member 17 binding agent","chemblIds":["CHEMBL4298199"],"targetName":"Tumor necrosis factor receptor superfamily member 17","targetType":"single protein","targets":["ENSG00000048462"],"references":[{"source":"FDA","ids":["https://www.fda.gov/media/147055/download"],"urls":["https://www.fda.gov/media/147055/download"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","chemblIds":["CHEMBL1648"],"targetName":"Voltage-gated L-type calcium channel","targetType":"protein family","targets":["ENSG00000151067","ENSG00000081248","ENSG00000157388","ENSG00000102001"],"references":[{"source":"Wikipedia","ids":["Clevidipine","Dihydropyridine","L-type_calcium_channel","Voltage-dependent_calcium_channel"],"urls":["http://en.wikipedia.org/wiki/Clevidipine","http://en.wikipedia.org/wiki/Dihydropyridine","http://en.wikipedia.org/wiki/L-type_calcium_channel","http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel"]},{"source":"DailyMed","ids":["archiveid=27627"],"urls":["http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=27627"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ig epsilon chain C region inhibitor","chemblIds":["CHEMBL2109456"],"targetName":"Ig epsilon chain C region","targetType":"single protein","targets":["ENSG00000211891"],"references":[{"source":"PubMed","ids":["24990880"],"urls":["http://europepmc.org/abstract/MED/24990880"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Lipopolysaccharide (LPS) inhibitor","chemblIds":["CHEMBL1743055"],"references":[{"source":"PubMed","ids":["21393169","24859907"],"urls":["http://europepmc.org/abstract/MED/21393169","http://europepmc.org/abstract/MED/24859907"]},{"source":"PMC","ids":["PMC3759427"],"urls":["http://europepmc.org/articles/PMC3759427"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA topoisomerase I inhibitor","chemblIds":["CHEMBL4297844"],"targetName":"DNA topoisomerase I","targetType":"single protein","targets":["ENSG00000198900"],"references":[{"source":"FDA","ids":["label/2019/761139s000lbl.pdf","label/2019/761139s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Envelope glycoprotein gp160 inhibitor","chemblIds":["CHEMBL2109442"],"targetName":"Envelope glycoprotein gp160","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["7576908"],"urls":["http://europepmc.org/abstract/MED/7576908"]}]}
{"actionType":"RELEASING AGENT","mechanismOfAction":"Norepinephrine transporter releasing agent","chemblIds":["CHEMBL1200724","CHEMBL1590"],"targetName":"Norepinephrine transporter","targetType":"single protein","targets":["ENSG00000103546"],"references":[{"source":"PubMed","ids":["12373557","19948186"],"urls":["http://europepmc.org/abstract/MED/12373557","http://europepmc.org/abstract/MED/19948186"]},{"source":"ISBN","ids":["9780702034718 PP. 191"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"Wikipedia","ids":["Adrenergic_agonist","Adrenergic_receptor","Decongestant","Pseudoephedrine"],"urls":["http://en.wikipedia.org/wiki/Adrenergic_agonist","http://en.wikipedia.org/wiki/Adrenergic_receptor","http://en.wikipedia.org/wiki/Decongestant","http://en.wikipedia.org/wiki/Pseudoephedrine"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Lewis Y antigen binding agent","chemblIds":["CHEMBL2109504"],"references":[{"source":"PubMed","ids":["19825951"],"urls":["http://europepmc.org/abstract/MED/19825951"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bcl-2-related protein A1 inhibitor","chemblIds":["CHEMBL2107358","CHEMBL408194"],"targetName":"Bcl-2-related protein A1","targetType":"single protein","targets":["ENSG00000140379"],"references":[{"source":"PubMed","ids":["16645636","18040043","18931344","16645636","18040043","18931344","16645636","18040043","18931344","16645636","18040043","18931344","16645636","18040043","18931344","16645636","18040043","18931344"],"urls":["http://europepmc.org/abstract/MED/16645636","http://europepmc.org/abstract/MED/18040043","http://europepmc.org/abstract/MED/18931344","http://europepmc.org/abstract/MED/16645636","http://europepmc.org/abstract/MED/18040043","http://europepmc.org/abstract/MED/18931344","http://europepmc.org/abstract/MED/16645636","http://europepmc.org/abstract/MED/18040043","http://europepmc.org/abstract/MED/18931344","http://europepmc.org/abstract/MED/16645636","http://europepmc.org/abstract/MED/18040043","http://europepmc.org/abstract/MED/18931344","http://europepmc.org/abstract/MED/16645636","http://europepmc.org/abstract/MED/18040043","http://europepmc.org/abstract/MED/18931344","http://europepmc.org/abstract/MED/16645636","http://europepmc.org/abstract/MED/18040043","http://europepmc.org/abstract/MED/18931344"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL1237072"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"PubMed","ids":["11324679","12762831","8478301"],"urls":["http://europepmc.org/abstract/MED/11324679","http://europepmc.org/abstract/MED/12762831","http://europepmc.org/abstract/MED/8478301"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Mu opioid receptor antagonist","chemblIds":["CHEMBL4297383"],"targetName":"Mu opioid receptor","targetType":"single protein","targets":["ENSG00000112038"],"references":[{"source":"PubMed","ids":["23147384","26141191"],"urls":["http://europepmc.org/abstract/MED/23147384","http://europepmc.org/abstract/MED/26141191"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine-protein kinase ATR inhibitor","chemblIds":["CHEMBL4647810"],"targetName":"Serine-protein kinase ATR","targetType":"single protein","targets":["ENSG00000175054"],"references":[{"source":"PubMed","ids":["31582533"],"urls":["http://europepmc.org/abstract/MED/31582533"]},{"source":"Other","ids":["https://cancerres.aacrjournals.org/content/77/13_Supplement/836"],"urls":["https://cancerres.aacrjournals.org/content/77/13_Supplement/836"]},{"source":"ClinicalTrials","ids":["NCT04616534"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT04616534"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL268164"],"references":[{"source":"PubMed","ids":["6122710","989475"],"urls":["http://europepmc.org/abstract/MED/6122710","http://europepmc.org/abstract/MED/989475"]}]}
{"actionType":"PARTIAL AGONIST","mechanismOfAction":"Serotonin 1a (5-HT1a) receptor partial agonist","chemblIds":["CHEMBL1200399","CHEMBL49"],"targetName":"Serotonin 1a (5-HT1a) receptor","targetType":"single protein","targets":["ENSG00000178394"],"references":[{"source":"FDA","ids":["label/2010/018731s051lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf"]},{"source":"Wikipedia","ids":["Buspirone"],"urls":["http://en.wikipedia.org/wiki/Buspirone"]}]}
{"actionType":"RELEASING AGENT","mechanismOfAction":"Norepinephrine transporter releasing agent","chemblIds":["CHEMBL3544906","CHEMBL3545985"],"targetName":"Norepinephrine transporter","targetType":"single protein","targets":["ENSG00000103546"],"references":[{"source":"PubMed","ids":["10605627","7902561","10605627","7902561"],"urls":["http://europepmc.org/abstract/MED/10605627","http://europepmc.org/abstract/MED/7902561","http://europepmc.org/abstract/MED/10605627","http://europepmc.org/abstract/MED/7902561"]},{"source":"DailyMed","ids":["setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1","setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Beta-secretase 1 inhibitor","chemblIds":["CHEMBL4204869"],"targetName":"Beta-secretase 1","targetType":"single protein","targets":["ENSG00000186318"],"references":[{"source":"PubMed","ids":["25621019"],"urls":["http://europepmc.org/abstract/MED/25621019"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Thrombin inhibitor","chemblIds":["CHEMBL1201666"],"targetName":"Thrombin","targetType":"single protein","targets":["ENSG00000180210"],"references":[{"source":"FDA","ids":["label/2006/020807s011lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020807s011lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscle-type nicotinic acetylcholine receptor antagonist","chemblIds":["CHEMBL1200722","CHEMBL1201206"],"targetName":"Muscle-type nicotinic acetylcholine receptor","targetType":"protein complex group","targets":["ENSG00000138435","ENSG00000196811","ENSG00000170175","ENSG00000135902","ENSG00000108556"],"references":[{"source":"PubMed","ids":["12426786","1748153","9227834"],"urls":["http://europepmc.org/abstract/MED/12426786","http://europepmc.org/abstract/MED/1748153","http://europepmc.org/abstract/MED/9227834"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL3545214"],"references":[{"source":"PubMed","ids":["16204081"],"urls":["http://europepmc.org/abstract/MED/16204081"]},{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=683963"],"urls":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=683963"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase PLK1 inhibitor","chemblIds":["CHEMBL3545354"],"targetName":"Serine/threonine-protein kinase PLK1","targetType":"single protein","targets":["ENSG00000166851"],"references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800040745"],"urls":["http://adisinsight.springer.com/drugs/800040745"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Apoptosis regulator Bcl-2 inhibitor","chemblIds":["CHEMBL443684"],"targetName":"Apoptosis regulator Bcl-2","targetType":"single protein","targets":["ENSG00000171791"],"references":[{"source":"PubMed","ids":["18451170","21094089","18451170","18451170","21094089"],"urls":["http://europepmc.org/abstract/MED/18451170","http://europepmc.org/abstract/MED/21094089","http://europepmc.org/abstract/MED/18451170","http://europepmc.org/abstract/MED/18451170","http://europepmc.org/abstract/MED/21094089"]}]}
